eecp presentation
TRANSCRIPT
Topics to be covered.Company profile.What is EECP ?Working principle of EECP.Why EECP?Objective of the EECP.Who is EECP for?Mode of therapy.Accreditations.Limitations of EECP?Global and Indian market of EECP.Competitors.
Company profile.VSK Medical Limited-a global market leader in
ECP&EECP
Address:-1st Floor No.342, 1st Floor East Facing9th Main Dollars Colony, J.P Nagar, 4th Phase,Bangalore, 560078, India
Main products: EECP ALL IN ONE MODEL, EECP PAEDIATRIC MODEL AND EECP MOVABLE MODEL.(By PSK China & Vasomedical Solution.)
Main market: Eastern Asia, South Asia, Middle East, Central America and Southeast Asia. Apart from USA & China.
Vasomedical Lumenair™ All-In-One EECP® Therapy System
Vasomedical AngioNew®-V Mobile EECP® Therapy System
Vasomedical AngioNew®-VI All-In-One EECP® Therapy System
EECP ?EECP stands for Enhanced External
Counterpulsation Therapy.
It’s a new method to relieve heart pain by creating new vessels(collaterals) in the heart by pushing blood into the heart.
EECP helps grow new collaterals for blood to flow, like a natural bypass around blocked arteries.
EECP is a non-invasive treatment.
Working principle of EECP.Series of 3 cuffs wrapped around calves,
lower thighs, upper thighs and buttocks.Cuffs sequentially inflate with air when
the heart relaxes and deflate when the heart pumps.
Objective of EECP.To assess the effectiveness, and cost
effectiveness of EECP in patients with severe anginal symptoms, secondary to chronic coronary disease, who are not candidates for surgical/percutaneous revascularization procedures (e.g., angioplasty, coronary bypass surgery).
Benefits of
EECP
Neurological
disorder
Erectile dysfunctio
n
Stroke and kidney
impairment
Diabetic patient.
Sports Enhan-cemen
t
Vision and
hearing
disorder
Autoim-
mune diseas
e
Lymph-atic syste
m
Who is EECP for?
EECP therapy is indicated for patients with coronary artery disease who either cannot undergo angioplasty or bypass surgery, or have persistent anginal symptoms following angioplasty or bypass surgery.
Patients with heart pain, low energy level, shortness of breath, fatigue and diabetic patients.
CAD – Coronary Artery DiseaseCHD – Coronary Heart DiseasePVD – Peripheral Vascular DiseaseED – Erectile DysfunctionCardiac chest painCongestive heart failureHigh blood pressureCardio-myopathyPeripheral neuropathyPeripheral vascular diseaseEdema, or venous insufficiencyChronic fatigue Intestinal vascular insufficiencyLymphatic System Parkinson’s diseasekidney diseasePeripheral vascular disease hearing loss and tinnitus vision impairment
Mode of therapy.A total of 35 hours is required.
Regimen:1 hour daily.
At least 5 days per week for 7 weeks.
Accreditations.FDA approved.CE certified.Method adopted by various medical
branches like :American Medicare.European Society of Cardiology (ESC).Chinese Medical Association (CMA).American College of Cardiology (ACC)
etc..
Limitations of EECP?Aortic stenosis , Dialated Cardiomyopathy .Uncontrolled hypertension.Blood Pressure >160/100mmhg.Brain Hemorrhage.Heart Rate >120bpm.Pregnant women.Deep vein Thrombosis.Infection on limbs.Arrhythmias that interfere with machine
triggering.
Global and Indian market of EECP.Major market in
CHINA and USA.Progressive stage
in INDIA with numerous centers.
Bangalore ChennaiDelhi Deharadun Mumbai
JaipurKolkataKeralaPuneSuratBihar etc..